U.S., Nov. 15 -- ClinicalTrials.gov registry received information related to the study (NCT04144218) titled 'Evaluation of the Efficacy and Safety of Lacosamide in Pediatric Patients With Epilepsy' on Oct. 17.

Brief Summary: Children with focal refractory epilepsy will be routinely included in the collection of history, blood routine, biochemistry, EEG, MRI and 18F-FDG PET to determine the location of the epileptogenic focus and to assess the severity of the disease. This international multicenter clinical trial uses a double-blind, randomized, controlled study to evaluate the safety and efficacy of LCM in clinical applications in children with epilepsy.

Study Type: Interventional

Condition: Epilepsy

Intervention: * Drug: Lacosamide

Th...